+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Nutrition Supplements Market in Europe 2026-2030

  • PDF Icon

    Report

  • 228 Pages
  • January 2026
  • Region: Europe
  • TechNavio
  • ID: 5847340
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The nutrition supplements market in europe is forecasted to grow by USD 27.6 billion during 2025-2030, accelerating at a CAGR of 6.4% during the forecast period. The report on the nutrition supplements market in europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by escalating consumer focus on preventative healthcare and longevity research, technological innovation fueling hyper-personalized nutrition, mainstreaming of sports nutrition into everyday lifestyles.

The study identifies the transformation of nutrition with ai and genetic profiling as one of the prime reasons driving the nutrition supplements market in europe growth during the next few years. Also, sustainable and plant-based ingredient innovation and integration of mental wellness and nootropic formulations will lead to sizable demand in the market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The nutrition supplements market in europe is segmented as below:

By Distribution Channel

  • Offline
  • Online

By Type

  • Vitamins
  • Botanicals
  • Proteins and amino acids
  • Minerals
  • Others

By Formulation

  • Tablets
  • Capsules
  • Powders
  • Gummies
  • Others

By Region

  • Europe

The report covers the following areas:

  • Nutrition supplements market in europe sizing
  • Nutrition supplements market in europe forecast
  • Nutrition supplements market in europe industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading market vendors that include: Abbott Laboratories, Amway Corp., Archer Daniels Midland Co., Arkopharma Laboratories, BASF SE, Bayer AG, DSM Firmenich AG, Evonik Industries AG, Glanbia Plc, Haleon Plc, Herbalife International, Nestle SA, Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group Plc. Also, the nutrition supplements market in europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Country Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Distribution Channel
  • Executive Summary - Chart on Market Segmentation by Type
  • Executive Summary - Chart on Market Segmentation by Formulation
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
  • Overview on factors of disruption
2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
3 Market Landscape
3.1 Market ecosystem
  • Chart on Parent Market
  • Data Table on - Parent Market
3.2 Market characteristics
  • Chart on Market characteristics analysis
3.3 Value chain analysis
  • Chart on Value chain analysis
4 Market Sizing
4.1 Market definition
  • Data Table on Offerings of companies included in the market definition
4.2 Market segment analysis
  • Market segments
4.3 Market size 2025
4.4 Market outlook: Forecast for 2025-2030
  • Chart on Europe - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Regional - Market size and forecast 2025-2030 ($ billion)
  • Chart on Europe: Year-over-year growth 2025-2030 (%)
  • Data Table on Regional - Market size and forecast 2025-2030 ($ billion)
5 Historic Market Size
5.1 Nutrition Supplements Market in Europe 2020-2024
  • Historic Market Size - Data Table on Nutrition Supplements Market in Europe 2020-2024 ($ billion)
5.2 Distribution Channel segment analysis 2020-2024
  • Historic Market Size - Distribution Channel Segment 2020-2024 ($ billion)
5.3 Type segment analysis 2020-2024
  • Historic Market Size - Type Segment 2020-2024 ($ billion)
5.4 Formulation segment analysis 2020-2024
  • Historic Market Size - Formulation Segment 2020-2024 ($ billion)
5.5 Geography segment analysis 2020-2024
  • Historic Market Size - Geography Segment 2020-2024 ($ billion)
6 Qualitative Analysis
6.1 Impact of AI in Nutrition Supplements Market in Europe
7 Five Forces Analysis
7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
7.7 Market condition
  • Chart on Market condition - Five forces 2025 and 2030
8 Market Segmentation by Distribution Channel
8.1 Market segments
  • Chart on Distribution Channel - Market share 2025-2030 (%)
  • Data Table on Distribution Channel - Market share 2025-2030 (%)
8.2 Comparison by Distribution Channel
  • Chart on Comparison by Distribution Channel
  • Data Table on Comparison by Distribution Channel
8.3 Offline - Market size and forecast 2025-2030
  • Chart on Offline - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Offline - Market size and forecast 2025-2030 ($ billion)
  • Chart on Offline - Year-over-year growth 2025-2030 (%)
  • Data Table on Offline - Year-over-year growth 2025-2030 (%)
8.4 Online - Market size and forecast 2025-2030
  • Chart on Online - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Online - Market size and forecast 2025-2030 ($ billion)
  • Chart on Online - Year-over-year growth 2025-2030 (%)
  • Data Table on Online - Year-over-year growth 2025-2030 (%)
8.5 Market opportunity by Distribution Channel
  • Market opportunity by Distribution Channel ($ billion)
  • Data Table on Market opportunity by Distribution Channel ($ billion)
9 Market Segmentation by Type
9.1 Market segments
  • Chart on Type - Market share 2025-2030 (%)
  • Data Table on Type - Market share 2025-2030 (%)
9.2 Comparison by Type
  • Chart on Comparison by Type
  • Data Table on Comparison by Type
9.3 Vitamins - Market size and forecast 2025-2030
  • Chart on Vitamins - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Vitamins - Market size and forecast 2025-2030 ($ billion)
  • Chart on Vitamins - Year-over-year growth 2025-2030 (%)
  • Data Table on Vitamins - Year-over-year growth 2025-2030 (%)
9.4 Botanicals - Market size and forecast 2025-2030
  • Chart on Botanicals - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Botanicals - Market size and forecast 2025-2030 ($ billion)
  • Chart on Botanicals - Year-over-year growth 2025-2030 (%)
  • Data Table on Botanicals - Year-over-year growth 2025-2030 (%)
9.5 Proteins and amino acids - Market size and forecast 2025-2030
  • Chart on Proteins and amino acids - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Proteins and amino acids - Market size and forecast 2025-2030 ($ billion)
  • Chart on Proteins and amino acids - Year-over-year growth 2025-2030 (%)
  • Data Table on Proteins and amino acids - Year-over-year growth 2025-2030 (%)
9.6 Minerals - Market size and forecast 2025-2030
  • Chart on Minerals - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Minerals - Market size and forecast 2025-2030 ($ billion)
  • Chart on Minerals - Year-over-year growth 2025-2030 (%)
  • Data Table on Minerals - Year-over-year growth 2025-2030 (%)
9.7 Others - Market size and forecast 2025-2030
  • Chart on Others - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Others - Market size and forecast 2025-2030 ($ billion)
  • Chart on Others - Year-over-year growth 2025-2030 (%)
  • Data Table on Others - Year-over-year growth 2025-2030 (%)
9.8 Market opportunity by Type
  • Market opportunity by Type ($ billion)
  • Data Table on Market opportunity by Type ($ billion)
10 Market Segmentation by Formulation
10.1 Market segments
  • Chart on Formulation - Market share 2025-2030 (%)
  • Data Table on Formulation - Market share 2025-2030 (%)
10.2 Comparison by Formulation
  • Chart on Comparison by Formulation
  • Data Table on Comparison by Formulation
10.3 Tablets - Market size and forecast 2025-2030
  • Chart on Tablets - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Tablets - Market size and forecast 2025-2030 ($ billion)
  • Chart on Tablets - Year-over-year growth 2025-2030 (%)
  • Data Table on Tablets - Year-over-year growth 2025-2030 (%)
10.4 Capsules - Market size and forecast 2025-2030
  • Chart on Capsules - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Capsules - Market size and forecast 2025-2030 ($ billion)
  • Chart on Capsules - Year-over-year growth 2025-2030 (%)
  • Data Table on Capsules - Year-over-year growth 2025-2030 (%)
10.5 Powders - Market size and forecast 2025-2030
  • Chart on Powders - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Powders - Market size and forecast 2025-2030 ($ billion)
  • Chart on Powders - Year-over-year growth 2025-2030 (%)
  • Data Table on Powders - Year-over-year growth 2025-2030 (%)
10.6 Gummies - Market size and forecast 2025-2030
  • Chart on Gummies - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Gummies - Market size and forecast 2025-2030 ($ billion)
  • Chart on Gummies - Year-over-year growth 2025-2030 (%)
  • Data Table on Gummies - Year-over-year growth 2025-2030 (%)
10.7 Others - Market size and forecast 2025-2030
  • Chart on Others - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Others - Market size and forecast 2025-2030 ($ billion)
  • Chart on Others - Year-over-year growth 2025-2030 (%)
  • Data Table on Others - Year-over-year growth 2025-2030 (%)
10.8 Market opportunity by Formulation
  • Market opportunity by Formulation ($ billion)
  • Data Table on Market opportunity by Formulation ($ billion)
11 Customer Landscape
11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
  • Chart on Market share by geography - 2025-2030 (%)
  • Data Table on Market share by geography - 2025-2030 (%)
12.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
12.3 Italy - Market size and forecast 2025-2030
  • Chart on Italy - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Italy - Market size and forecast 2025-2030 ($ billion)
  • Chart on Italy - Year-over-year growth 2025-2030 (%)
  • Data Table on Italy - Year-over-year growth 2025-2030 (%)
12.4 Germany - Market size and forecast 2025-2030
  • Chart on Germany - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Germany - Market size and forecast 2025-2030 ($ billion)
  • Chart on Germany - Year-over-year growth 2025-2030 (%)
  • Data Table on Germany - Year-over-year growth 2025-2030 (%)
12.5 France - Market size and forecast 2025-2030
  • Chart on France - Market size and forecast 2025-2030 ($ billion)
  • Data Table on France - Market size and forecast 2025-2030 ($ billion)
  • Chart on France - Year-over-year growth 2025-2030 (%)
  • Data Table on France - Year-over-year growth 2025-2030 (%)
12.6 UK - Market size and forecast 2025-2030
  • Chart on UK - Market size and forecast 2025-2030 ($ billion)
  • Data Table on UK - Market size and forecast 2025-2030 ($ billion)
  • Chart on UK - Year-over-year growth 2025-2030 (%)
  • Data Table on UK - Year-over-year growth 2025-2030 (%)
12.7 Rest of Europe - Market size and forecast 2025-2030
  • Chart on Rest of Europe - Market size and forecast 2025-2030 ($ billion)
  • Data Table on Rest of Europe - Market size and forecast 2025-2030 ($ billion)
  • Chart on Rest of Europe - Year-over-year growth 2025-2030 (%)
  • Data Table on Rest of Europe - Year-over-year growth 2025-2030 (%)
12.8 Market opportunity by geography
  • Market opportunity by geography ($ billion)
  • Data Table on Market opportunity by geography ($ billion)
13 Drivers, Challenges, and Opportunity
13.1 Market drivers
  • Escalating consumer focus on preventative healthcare and longevity research
  • Technological innovation fueling hyper-personalized nutrition
  • Mainstreaming of sports nutrition into everyday lifestyles
13.2 Market challenges
  • Regulatory fragmentation and complexity of compliance standards
  • Supply chain disruptions and scarcity of premium raw materials
  • Transparency dilemmas and weakening consumer confidence
13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
13.4 Market opportunities
  • Transformation of nutrition with AI and genetic profiling
  • Sustainable and plant-based ingredient innovation
  • Integration of mental wellness and nootropic formulations
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
  • Overview on factors of disruption
14.4 Industry risks
  • Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
15.2 Company ranking index
15.3 Market positioning of companies
  • Matrix on companies position and classification
15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
15.5 Amway Corp.
  • Amway Corp. - Overview
  • Amway Corp. - Product / Service
  • Amway Corp. - Key news
  • Amway Corp. - Key offerings
  • SWOT
15.6 Archer Daniels Midland Co.
  • Archer Daniels Midland Co. - Overview
  • Archer Daniels Midland Co. - Business segments
  • Archer Daniels Midland Co. - Key news
  • Archer Daniels Midland Co. - Key offerings
  • Archer Daniels Midland Co. - Segment focus
  • SWOT
15.7 Arkopharma Laboratories
  • Arkopharma Laboratories - Overview
  • Arkopharma Laboratories - Product / Service
  • Arkopharma Laboratories - Key offerings
  • SWOT
15.8 BASF SE
  • BASF SE - Overview
  • BASF SE - Business segments
  • BASF SE - Key news
  • BASF SE - Key offerings
  • BASF SE - Segment focus
  • SWOT
15.9 Bayer AG
  • Bayer AG - Overview
  • Bayer AG - Business segments
  • Bayer AG - Key news
  • Bayer AG - Key offerings
  • Bayer AG - Segment focus
  • SWOT
15.10 DSM Firmenich AG
  • DSM Firmenich AG - Overview
  • DSM Firmenich AG - Product / Service
  • DSM Firmenich AG - Key offerings
  • SWOT
15.11 Evonik Industries AG
  • Evonik Industries AG - Overview
  • Evonik Industries AG - Business segments
  • Evonik Industries AG - Key news
  • Evonik Industries AG - Key offerings
  • Evonik Industries AG - Segment focus
  • SWOT
15.12 Glanbia Plc
  • Glanbia Plc - Overview
  • Glanbia Plc - Business segments
  • Glanbia Plc - Key news
  • Glanbia Plc - Key offerings
  • Glanbia Plc - Segment focus
  • SWOT
15.13 Haleon Plc
  • Haleon Plc - Overview
  • Haleon Plc - Business segments
  • Haleon Plc - Key offerings
  • Haleon Plc - Segment focus
  • SWOT
15.14 Herbalife International
  • Herbalife International - Overview
  • Herbalife International - Product / Service
  • Herbalife International - Key news
  • Herbalife International - Key offerings
  • SWOT
15.15 Nestle SA
  • Nestle SA - Overview
  • Nestle SA - Business segments
  • Nestle SA - Key news
  • Nestle SA - Key offerings
  • Nestle SA - Segment focus
  • SWOT
15.16 Perrigo Co. Plc
  • Perrigo Co. Plc - Overview
  • Perrigo Co. Plc - Business segments
  • Perrigo Co. Plc - Key offerings
  • Perrigo Co. Plc - Segment focus
  • SWOT
15.17 Pfizer Inc.
  • Pfizer Inc. - Overview
  • Pfizer Inc. - Product / Service
  • Pfizer Inc. - Key news
  • Pfizer Inc. - Key offerings
  • SWOT
15.18 Reckitt Benckiser Group Plc
  • Reckitt Benckiser Group Plc - Overview
  • Reckitt Benckiser Group Plc - Business segments
  • Reckitt Benckiser Group Plc - Key news
  • Reckitt Benckiser Group Plc - Key offerings
  • Reckitt Benckiser Group Plc - Segment focus
  • SWOT
16 Appendix
16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
16.3 Currency conversion rates for US$
16.4 Research methodology
16.5 Data procurement
  • Information sources
16.6 Data validation
  • Data validation
16.7 Validation techniques employed for market sizing
16.8 Data synthesis
16.9 360-degree market analysis
16.10 List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Country Market Characteristics
Exhibits 4: Executive Summary - Chart on Market by Geography
Exhibits 5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Market Segmentation by Formulation
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2025 and 2030
Exhibits 15: Chart on Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Chart on Market characteristics analysis
Exhibits 18: Chart on Value chain analysis
Exhibits 19: Data Table on Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Europe - Market size and forecast 2025-2030 ($ billion)
Exhibits 22: Data Table on Regional - Market size and forecast 2025-2030 ($ billion)
Exhibits 23: Chart on Europe: Year-over-year growth 2025-2030 (%)
Exhibits 24: Data Table on Regional - Market size and forecast 2025-2030 ($ billion)
Exhibits 25: Historic Market Size - Data Table on Nutrition Supplements Market in Europe 2020-2024 ($ billion)
Exhibits 26: Historic Market Size - Distribution Channel Segment 2020-2024 ($ billion)
Exhibits 27: Historic Market Size - Type Segment 2020-2024 ($ billion)
Exhibits 28: Historic Market Size - Formulation Segment 2020-2024 ($ billion)
Exhibits 29: Historic Market Size - Geography Segment 2020-2024 ($ billion)
Exhibits 30: Five forces analysis - Comparison between 2025 and 2030
Exhibits 31: Bargaining power of buyers - Impact of key factors 2025 and 2030
Exhibits 32: Bargaining power of suppliers - Impact of key factors in 2025 and 2030
Exhibits 33: Threat of new entrants - Impact of key factors in 2025 and 2030
Exhibits 34: Threat of substitutes - Impact of key factors in 2025 and 2030
Exhibits 35: Threat of rivalry - Impact of key factors in 2025 and 2030
Exhibits 36: Chart on Market condition - Five forces 2025 and 2030
Exhibits 37: Chart on Distribution Channel - Market share 2025-2030 (%)
Exhibits 38: Data Table on Distribution Channel - Market share 2025-2030 (%)
Exhibits 39: Chart on Comparison by Distribution Channel
Exhibits 40: Data Table on Comparison by Distribution Channel
Exhibits 41: Chart on Offline - Market size and forecast 2025-2030 ($ billion)
Exhibits 42: Data Table on Offline - Market size and forecast 2025-2030 ($ billion)
Exhibits 43: Chart on Offline - Year-over-year growth 2025-2030 (%)
Exhibits 44: Data Table on Offline - Year-over-year growth 2025-2030 (%)
Exhibits 45: Chart on Online - Market size and forecast 2025-2030 ($ billion)
Exhibits 46: Data Table on Online - Market size and forecast 2025-2030 ($ billion)
Exhibits 47: Chart on Online - Year-over-year growth 2025-2030 (%)
Exhibits 48: Data Table on Online - Year-over-year growth 2025-2030 (%)
Exhibits 49: Market opportunity by Distribution Channel ($ billion)
Exhibits 50: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits 51: Chart on Type - Market share 2025-2030 (%)
Exhibits 52: Data Table on Type - Market share 2025-2030 (%)
Exhibits 53: Chart on Comparison by Type
Exhibits 54: Data Table on Comparison by Type
Exhibits 55: Chart on Vitamins - Market size and forecast 2025-2030 ($ billion)
Exhibits 56: Data Table on Vitamins - Market size and forecast 2025-2030 ($ billion)
Exhibits 57: Chart on Vitamins - Year-over-year growth 2025-2030 (%)
Exhibits 58: Data Table on Vitamins - Year-over-year growth 2025-2030 (%)
Exhibits 59: Chart on Botanicals - Market size and forecast 2025-2030 ($ billion)
Exhibits 60: Data Table on Botanicals - Market size and forecast 2025-2030 ($ billion)
Exhibits 61: Chart on Botanicals - Year-over-year growth 2025-2030 (%)
Exhibits 62: Data Table on Botanicals - Year-over-year growth 2025-2030 (%)
Exhibits 63: Chart on Proteins and amino acids - Market size and forecast 2025-2030 ($ billion)
Exhibits 64: Data Table on Proteins and amino acids - Market size and forecast 2025-2030 ($ billion)
Exhibits 65: Chart on Proteins and amino acids - Year-over-year growth 2025-2030 (%)
Exhibits 66: Data Table on Proteins and amino acids - Year-over-year growth 2025-2030 (%)
Exhibits 67: Chart on Minerals - Market size and forecast 2025-2030 ($ billion)
Exhibits 68: Data Table on Minerals - Market size and forecast 2025-2030 ($ billion)
Exhibits 69: Chart on Minerals - Year-over-year growth 2025-2030 (%)
Exhibits 70: Data Table on Minerals - Year-over-year growth 2025-2030 (%)
Exhibits 71: Chart on Others - Market size and forecast 2025-2030 ($ billion)
Exhibits 72: Data Table on Others - Market size and forecast 2025-2030 ($ billion)
Exhibits 73: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibits 74: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibits 75: Market opportunity by Type ($ billion)
Exhibits 76: Data Table on Market opportunity by Type ($ billion)
Exhibits 77: Chart on Formulation - Market share 2025-2030 (%)
Exhibits 78: Data Table on Formulation - Market share 2025-2030 (%)
Exhibits 79: Chart on Comparison by Formulation
Exhibits 80: Data Table on Comparison by Formulation
Exhibits 81: Chart on Tablets - Market size and forecast 2025-2030 ($ billion)
Exhibits 82: Data Table on Tablets - Market size and forecast 2025-2030 ($ billion)
Exhibits 83: Chart on Tablets - Year-over-year growth 2025-2030 (%)
Exhibits 84: Data Table on Tablets - Year-over-year growth 2025-2030 (%)
Exhibits 85: Chart on Capsules - Market size and forecast 2025-2030 ($ billion)
Exhibits 86: Data Table on Capsules - Market size and forecast 2025-2030 ($ billion)
Exhibits 87: Chart on Capsules - Year-over-year growth 2025-2030 (%)
Exhibits 88: Data Table on Capsules - Year-over-year growth 2025-2030 (%)
Exhibits 89: Chart on Powders - Market size and forecast 2025-2030 ($ billion)
Exhibits 90: Data Table on Powders - Market size and forecast 2025-2030 ($ billion)
Exhibits 91: Chart on Powders - Year-over-year growth 2025-2030 (%)
Exhibits 92: Data Table on Powders - Year-over-year growth 2025-2030 (%)
Exhibits 93: Chart on Gummies - Market size and forecast 2025-2030 ($ billion)
Exhibits 94: Data Table on Gummies - Market size and forecast 2025-2030 ($ billion)
Exhibits 95: Chart on Gummies - Year-over-year growth 2025-2030 (%)
Exhibits 96: Data Table on Gummies - Year-over-year growth 2025-2030 (%)
Exhibits 97: Chart on Others - Market size and forecast 2025-2030 ($ billion)
Exhibits 98: Data Table on Others - Market size and forecast 2025-2030 ($ billion)
Exhibits 99: Chart on Others - Year-over-year growth 2025-2030 (%)
Exhibits 100: Data Table on Others - Year-over-year growth 2025-2030 (%)
Exhibits 101: Market opportunity by Formulation ($ billion)
Exhibits 102: Data Table on Market opportunity by Formulation ($ billion)
Exhibits 103: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 104: Chart on Market share by geography - 2025-2030 (%)
Exhibits 105: Data Table on Market share by geography - 2025-2030 (%)
Exhibits 106: Chart on Geographic comparison
Exhibits 107: Data Table on Geographic comparison
Exhibits 108: Chart on Italy - Market size and forecast 2025-2030 ($ billion)
Exhibits 109: Data Table on Italy - Market size and forecast 2025-2030 ($ billion)
Exhibits 110: Chart on Italy - Year-over-year growth 2025-2030 (%)
Exhibits 111: Data Table on Italy - Year-over-year growth 2025-2030 (%)
Exhibits 112: Chart on Germany - Market size and forecast 2025-2030 ($ billion)
Exhibits 113: Data Table on Germany - Market size and forecast 2025-2030 ($ billion)
Exhibits 114: Chart on Germany - Year-over-year growth 2025-2030 (%)
Exhibits 115: Data Table on Germany - Year-over-year growth 2025-2030 (%)
Exhibits 116: Chart on France - Market size and forecast 2025-2030 ($ billion)
Exhibits 117: Data Table on France - Market size and forecast 2025-2030 ($ billion)
Exhibits 118: Chart on France - Year-over-year growth 2025-2030 (%)
Exhibits 119: Data Table on France - Year-over-year growth 2025-2030 (%)
Exhibits 120: Chart on UK - Market size and forecast 2025-2030 ($ billion)
Exhibits 121: Data Table on UK - Market size and forecast 2025-2030 ($ billion)
Exhibits 122: Chart on UK - Year-over-year growth 2025-2030 (%)
Exhibits 123: Data Table on UK - Year-over-year growth 2025-2030 (%)
Exhibits 124: Chart on Rest of Europe - Market size and forecast 2025-2030 ($ billion)
Exhibits 125: Data Table on Rest of Europe - Market size and forecast 2025-2030 ($ billion)
Exhibits 126: Chart on Rest of Europe - Year-over-year growth 2025-2030 (%)
Exhibits 127: Data Table on Rest of Europe - Year-over-year growth 2025-2030 (%)
Exhibits 128: Market opportunity by geography ($ billion)
Exhibits 129: Data Table on Market opportunity by geography ($ billion)
Exhibits 130: Impact of drivers and challenges in 2025 and 2030
Exhibits 131: Overview on criticality of inputs and factors of differentiation
Exhibits 132: Overview on factors of disruption
Exhibits 133: Impact of key risks on business
Exhibits 134: Companies covered
Exhibits 135: Company ranking index
Exhibits 136: Matrix on companies position and classification
Exhibits 137: Abbott Laboratories - Overview
Exhibits 138: Abbott Laboratories - Business segments
Exhibits 139: Abbott Laboratories - Key offerings
Exhibits 140: Abbott Laboratories - Segment focus
Exhibits 141: SWOT
Exhibits 142: Amway Corp. - Overview
Exhibits 143: Amway Corp. - Product / Service
Exhibits 144: Amway Corp. - Key news
Exhibits 145: Amway Corp. - Key offerings
Exhibits 146: SWOT
Exhibits 147: Archer Daniels Midland Co. - Overview
Exhibits 148: Archer Daniels Midland Co. - Business segments
Exhibits 149: Archer Daniels Midland Co. - Key news
Exhibits 150: Archer Daniels Midland Co. - Key offerings
Exhibits 151: Archer Daniels Midland Co. - Segment focus
Exhibits 152: SWOT
Exhibits 153: Arkopharma Laboratories - Overview
Exhibits 154: Arkopharma Laboratories - Product / Service
Exhibits 155: Arkopharma Laboratories - Key offerings
Exhibits 156: SWOT
Exhibits 157: BASF SE - Overview
Exhibits 158: BASF SE - Business segments
Exhibits 159: BASF SE - Key news
Exhibits 160: BASF SE - Key offerings
Exhibits 161: BASF SE - Segment focus
Exhibits 162: SWOT
Exhibits 163: Bayer AG - Overview
Exhibits 164: Bayer AG - Business segments
Exhibits 165: Bayer AG - Key news
Exhibits 166: Bayer AG - Key offerings
Exhibits 167: Bayer AG - Segment focus
Exhibits 168: SWOT
Exhibits 169: DSM Firmenich AG - Overview
Exhibits 170: DSM Firmenich AG - Product / Service
Exhibits 171: DSM Firmenich AG - Key offerings
Exhibits 172: SWOT
Exhibits 173: Evonik Industries AG - Overview
Exhibits 174: Evonik Industries AG - Business segments
Exhibits 175: Evonik Industries AG - Key news
Exhibits 176: Evonik Industries AG - Key offerings
Exhibits 177: Evonik Industries AG - Segment focus
Exhibits 178: SWOT
Exhibits 179: Glanbia Plc - Overview
Exhibits 180: Glanbia Plc - Business segments
Exhibits 181: Glanbia Plc - Key news
Exhibits 182: Glanbia Plc - Key offerings
Exhibits 183: Glanbia Plc - Segment focus
Exhibits 184: SWOT
Exhibits 185: Haleon Plc - Overview
Exhibits 186: Haleon Plc - Business segments
Exhibits 187: Haleon Plc - Key offerings
Exhibits 188: Haleon Plc - Segment focus
Exhibits 189: SWOT
Exhibits 190: Herbalife International - Overview
Exhibits 191: Herbalife International - Product / Service
Exhibits 192: Herbalife International - Key news
Exhibits 193: Herbalife International - Key offerings
Exhibits 194: SWOT
Exhibits 195: Nestle SA - Overview
Exhibits 196: Nestle SA - Business segments
Exhibits 197: Nestle SA - Key news
Exhibits 198: Nestle SA - Key offerings
Exhibits 199: Nestle SA - Segment focus
Exhibits 200: SWOT
Exhibits 201: Perrigo Co. Plc - Overview
Exhibits 202: Perrigo Co. Plc - Business segments
Exhibits 203: Perrigo Co. Plc - Key offerings
Exhibits 204: Perrigo Co. Plc - Segment focus
Exhibits 205: SWOT
Exhibits 206: Pfizer Inc. - Overview
Exhibits 207: Pfizer Inc. - Product / Service
Exhibits 208: Pfizer Inc. - Key news
Exhibits 209: Pfizer Inc. - Key offerings
Exhibits 210: SWOT
Exhibits 211: Reckitt Benckiser Group Plc - Overview
Exhibits 212: Reckitt Benckiser Group Plc - Business segments
Exhibits 213: Reckitt Benckiser Group Plc - Key news
Exhibits 214: Reckitt Benckiser Group Plc - Key offerings
Exhibits 215: Reckitt Benckiser Group Plc - Segment focus
Exhibits 216: SWOT
Exhibits 217: Inclusions checklist
Exhibits 218: Exclusions checklist
Exhibits 219: Currency conversion rates for US$
Exhibits 220: Research methodology
Exhibits 221: Information sources
Exhibits 222: Data validation
Exhibits 223: Validation techniques employed for market sizing
Exhibits 224: Data synthesis
Exhibits 225: 360 degree market analysis

Executive Summary

The following companies are recognized as the key players in the global nutrition supplements market in europe: Abbott Laboratories, Amway Corp., Archer Daniels Midland Co., Arkopharma Laboratories, BASF SE, Bayer AG, DSM Firmenich AG, Evonik Industries AG, Glanbia Plc, Haleon Plc, Herbalife International, Nestle SA, Perrigo Co. Plc, Pfizer Inc., Reckitt Benckiser Group Plc.

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is transformation of nutrition with ai and genetic profiling."

According to the report, one of the major drivers for this market is the escalating consumer focus on preventative healthcare and longevity research.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Amway Corp.
  • Archer Daniels Midland Co.
  • Arkopharma Laboratories
  • BASF SE
  • Bayer AG
  • DSM Firmenich AG
  • Evonik Industries AG
  • Glanbia PLC
  • Haleon PLC
  • Herbalife International
  • Nestle SA
  • Perrigo Co. PLC
  • Pfizer Inc.
  • Reckitt Benckiser Group PLC